The partnership will concentrate on the development of two investigational antibodies

Move represents the latest phase of preparation for the opening of MSD’s new UK Discovery Centre

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence […]

NICE has recommended the use of semaglutide alongside a reduced-calorie diet and exercise

Collaboration will focus on innovative therapies for patients with a range of respiratory diseases